-
-
-
-
-
-
-
AxoGen, Inc. (AXGN) PT Raised to $50 at Citizens on Q1 Results - Record sales, High Growth
-
-
-
-
-
-
-
AXGN reports preliminary Q4 revenue of $59.9 million, up 21%
-
-
-
-
-
-
-
AxoGen (AXGN) 'Has Truly Differentiated Products' - Citizens
-
-
-
-
-
-
-
Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'
-
-
-
-
-
-
-
AxoGen, Inc. (AXGN) PT Raised to $25 at Jefferies
-
-
-
-
-
-
-
AxoGen (AXGN) Announces CFO Change
-
-
-
-
-
-
-
AxoGen, Inc. (AXGN) PT Raised to $26 at Canaccord Genuity
-
443,828 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

